Exact Mass: 384.23341760000005
Exact Mass Matches: 384.23341760000005
Found 500 metabolites which its exact mass value is equals to given mass value 384.23341760000005,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rhynchophylline
C22H28N2O4 (384.20489680000003)
Rhynchophylline is a member of indolizines. It has a role as a metabolite. Rhynchophylline is a natural product found in Uncaria tomentosa, Mitragyna inermis, and other organisms with data available. See also: Cats Claw (part of). A natural product found in Uncaria macrophylla. Annotation level-1 Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research. Rhyncholphylline is an alkaloid compound isolated from Uncaria rhynchophyllum. It has high biological activity and is widely used in anti-inflammatory, neuroprotective and other research.
IsoRhy
C22H28N2O4 (384.20489680000003)
Isorhynchophylline is a member of indolizines. It has a role as a metabolite. Isorhynchophylline is a natural product found in Uncaria tomentosa, Mitragyna inermis, and other organisms with data available. See also: Cats Claw (part of). A natural product found in Uncaria macrophylla. Isorhynchophylline is an alkaloid compound isolated from Uncaria. It can lower blood pressure, relax blood vessels, and protect nerves from damage caused by local ischemia. Isorhynchophylline is an alkaloid compound isolated from Uncaria. It can lower blood pressure, relax blood vessels, and protect nerves from damage caused by local ischemia.
Megestil
CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9660; ORIGINAL_PRECURSOR_SCAN_NO 9655 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9556; ORIGINAL_PRECURSOR_SCAN_NO 9555 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9613; ORIGINAL_PRECURSOR_SCAN_NO 9611 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9650; ORIGINAL_PRECURSOR_SCAN_NO 9648 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9684; ORIGINAL_PRECURSOR_SCAN_NO 9681 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9604; ORIGINAL_PRECURSOR_SCAN_NO 9603 D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D019167 - Appetite Stimulants C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone CONFIDENCE standard compound; INTERNAL_ID 2814 CONFIDENCE standard compound; INTERNAL_ID 8750 D000970 - Antineoplastic Agents
Bufogein
Bufogenin is a steroid lactone of Chan su (toad venom), a Chinese medicine obtained from the skin venom gland of toads. A specific Na/K-ATPase protein inhibitor, it is used as a cardiotonic and central nervous system (CNS) respiratory agent, an analgesic and anesthetic, and as a remedy for ulcers. It has a role as an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor. It is a steroid lactone and an epoxy steroid. It is functionally related to a bufanolide. Resibufogenin is a natural product found in Sclerophrys mauritanica, Bufo gargarizans, and other organisms with data available. Bufogenin is a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans; it is also one of the glycosides in the traditional Chinese medicine ChanSu, with potential cardiotonic activity. Although the mechanism of action of bufogenin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and has been shown to reduce blood pressure in a rat model of preeclampsia. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents C471 - Enzyme Inhibitor Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.
16-Methoxy-2,3-dihydro-3-hydroxytabersonine
C22H28N2O4 (384.20489680000003)
Ibutilide
Ibutilide is only found in individuals that have used or taken this drug. It is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. [Wikipedia]Ibutilide is a pure class III antiarrhythmic drug, used intravenously against atrial flutter and fibrillation. At a cellular level it exerts two main actions: induction of a persistent Na+ current sensitive to dihydropyridine Ca2+ channel blockers and potent inhibition of the cardiac rapid delayed rectifier K+ current, by binding within potassium channel pores. In other words, Ibutilide binds to and alters the activity of hERG potassium channels, delayed inward rectifier potassium (IKr) channels and L-type (dihydropyridine sensitive) calcium channels C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker
Ethynodiol Diacetate
Ethynodiol Diacetate is only found in individuals that have used or taken this drug. It is a synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive. [PubChem]Binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Ethynodiol Diacetate will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294
ST 24:5;O4
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Same as: D01617 D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294
Estra-1,3,5(10)-triene-3,16alpha-diol dipropionate
Acequinocyl
An acetate ester consisting of 1,4-naphthoquinone bearing acetoxy and dodecyl substituents at positions 2 and 3 respectively.
Cinnzeylanol
Constituent of the dried bark of Cinnamomum zeylanicum (cinnamon) and of Cinnamomum cassia (Chinese cinnamon) [CCD]. Cinnzeylanol is found in chinese cinnamon, ceylon cinnamon, and herbs and spices. Cinnzeylanol is found in ceylan cinnamon. Cinnzeylanol is a constituent of the dried bark of Cinnamomum zeylanicum (cinnamon) and of Cinnamomum cassia (Chinese cinnamon)
(-)-Pyrifolidine
(-)-Pyrifolidine is an alkaloid from Aspidosperma quebracho-blanco (quebracho). Alkaloid from Aspidosperma quebracho-blanco (quebracho).
20-Trihydroxy-leukotriene-B4
20-trihydroxy-leukotriene-B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region, and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by omega-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the omega-carboxy position and after CoA ester formation (PMID: 7649996, 17623009, 2853166, 6088485). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 20-trihydroxy-leukotriene-B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996, 17623009, 2853166, 6088485)
repaglinide aromatic amine
C22H28N2O4 (384.20489680000003)
repaglinide aromatic amine is a metabolite of repaglinide. Repaglinide is for the treatment of type II diabetes. It is supplied by Novo Nordisk. It is sold in Japan by Dainippon Sumitomo Pharma. Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs. (Wikipedia)
7-[(1S,2R,3R,4R)-3-(3-Hydroxy-4-phenylpent-1-enyl)-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid
4,4'-Bis(2-hydroxyethylethylamino)-2,2'-dimethylazobenzene
C22H32N4O2 (384.25251319999995)
Bufogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents
Estradiol dipropionate
Isorhynchophylline
C22H28N2O4 (384.20489680000003)
Magestin
Zipeprol
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
Corynoxine
C22H28N2O4 (384.20489680000003)
Corynoxine is a member of indolizines. It has a role as a metabolite. Corynoxine is a natural product found in Mitragyna speciosa, Uncaria attenuata, and Uncaria macrophylla with data available. A natural product found in Uncaria macrophylla. Corynoxine, a tetracyclic oxindole alkaloid, is isolated from the hooks of Uncaria rhynchophylla. Corynoxine is a natural autophagy enhancer that promotes the clearance of alpha-synuclein via Akt/mTOR pathway[1]. Corynoxine, a tetracyclic oxindole alkaloid, is isolated from the hooks of Uncaria rhynchophylla. Corynoxine is a natural autophagy enhancer that promotes the clearance of alpha-synuclein via Akt/mTOR pathway[1]. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer.
Corynoxine B
C22H28N2O4 (384.20489680000003)
A natural product found in Uncaria macrophylla. Corynoxine B is a member of indolizines. It has a role as a metabolite. Corynoxine B is a natural product found in Mitragyna speciosa and Uncaria macrophylla with data available. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer. Corynoxine B is a natural compound of indole alkaloids and a beclin-1-dependent autophagy inducer.
5-hydroxy-4-isopropyl-1-methyl-7-(3-oxobutyl)bicyclo[4.1.0]hept-3-yl cinnamate
Decahydro-alpha,4a-dimethyl-8-methylene-7-(1-oxo-3-phenylpropoxy)-2-naphthaleneacetic acid
19-Hydroxy-19,20-Dihydrovincamajine
C22H28N2O4 (384.20489680000003)
Epipolasinthiourea A
16-Methoxy-2,3-dihydro-3hydro-3-hydroxytabersoine
C22H28N2O4 (384.20489680000003)
5-[(Z)-12-(3,5-dihydroxyphenyl)dodec-8-enyl]benzene-1,3-diol
8-(4-Hydroxycinnamoyl)-(4beta,5alpha,8alpha)-1(10)-Guaiaene-8,11-diol|<4S,5S,7S,8S>-8-p-Coumaroyloxy-1(10)-guaien-11-ol|[4S,5S,7S,8S]-8-p-Coumaroyloxy-1(10)-guaien-11-ol
(1E,4S,5E,7R)-7-O-beta-D-glucopyranosylgermacra-1(10),5-diene
plakortolide Q
An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.
16-acetoxy-17-methoxy-coryn-16-en-9-ol|Gambirin
C22H28N2O4 (384.20489680000003)
(1alpha,2beta,3beta.5beta.6beta,7alpha,10alpha,14beta,16alpha)-2,3-Epoxy-5,6,7,10,14,16-grayanotoxanexol|Pieristoxin H|pieritoxin H
18-hydroxy-17-methoxy-yohimbane-16-carboxylic acid methyl ester|Deserpidinsaeure-methylester|Deserpidsaeure-methylester|Deserpinsaeure-methylester|ent-18alpha-Hydroxy-17beta-methoxy-15beta-yohimban-16alpha-carbonsaeure-methylester|ent-18alpha-hydroxy-17beta-methoxy-15beta-yohimban-16alpha-carboxylic acid methyl ester|Methyl deserpidate
C22H28N2O4 (384.20489680000003)
(16E)-9-Hydroxy-17-methoxy-coryn-16-en-16-carbonsaeure-methylester|(16E)-9-hydroxy-17-methoxy-coryn-16-ene-16-carboxylic acid methyl ester|Gambirine
C22H28N2O4 (384.20489680000003)
19-hydroxy-13-methoxy-ibogamine-18-carboxylic acid methyl ester|19-Hydroxy-isovoacangin|3-R/S-hydroxy-isovoacangine
C22H28N2O4 (384.20489680000003)
(16S,19E)-N1-(hydroxymethyl)isositsirikine|methyl (2S)-2-[(2R,3E,12bS)-3-ethylidene-1,2,3,4,6,7,12,12b-octahydro-12-(hydroxymethyl)indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
C22H28N2O4 (384.20489680000003)
12-Methoxy-vincamin|14-hydroxy-12-methoxy-14,15-dihydro-eburnamenine-14-carboxylic acid methyl ester|Methoxy-12-vincamin
C22H28N2O4 (384.20489680000003)
isobutyl 13-(1,3-benzdioxolo-5)trideca-2E,4E,12E-trienoate
3beta,16beta-dihydroxy-bufa-8(14),20,22-trienolide
1-(2,6-Dihydroxy-4-methoxyphenyl)-11-phenyl-1-undecanone|11-phenylundecanoyl-2,6-dihydroxy-4-methoxybenzene
3alpha-(2,3-epoxy-2-methylbutyryloxy)-4alpha,7alpha,11-trihydroxyeudesman-8-one
N(a)-Acetyl-11-methoxystrychnosplendine|Na-Acetyl-11-methoxystrychnosplendine
C22H28N2O4 (384.20489680000003)
(all-Z)-form-1-(2,4,6-Trihydroxyphenyl)-6,9,12,15-octadecatetraen-1-one,|phloroglucinol
(10S)-3c,8c,12c,14c,17c-Pentahydroxy-10r,13c-dimethyl-17t-((Xi)-1-hydroxy-aethyl)-(5tH,9tH)-hexadecahydro-1H-cyclopenta[a]phenanthren|(3?,5?,12?,14?,17S,20R)-Pregnane-3,8,12,14,17,20-hexol|3beta,8beta,12beta,14,17beta-Pentahydroxy-10,13-dimethyl-17alpha-((Xi)-1-hydroxy-aethyl)-5alpha,14beta-gonan|5alpha,14beta,17betaH-Pregnanhexol-(3beta,8,12beta,14,17,20xi)|5alpha-Dihydrosarcostin|diginanehexol-(3beta,8,12beta,14,17,20xi)|Diginanhexol-(3beta,8,12beta,14,17,20xi)|Dihydrosarcostin
lehualide E
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by methoxy groups at positions 3 and 4, a methyl group at position 5 and a (2E)-3-methyl-9-phenylnon-2-en-1-yl group at position 6. It has been isolated from the marine sponge of the genus Plakortis.
20(10->5)abeo-4,12-diacetoxy-4,5-secoabieta-5(10),6,8,11,13-pentaene|8-[4-(acetyloxy)-4-methylpentyl]-7-methyl-3-(1-methylethyl)naphthalen-2-yl acetate|diacetylcalocediol
(2R*,5S*,7S*,10S*)-10-methyl-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-6-methylenespiro[4.5]decan-7-ol
Methyl 11-methoxy-19-methyloxayohimban-16-carboxylate #
C22H28N2O4 (384.20489680000003)
(1R,4E,8R,10R)-8-O-[(E)-p-coumaroyl]-1,10-epoxyhumula-4(5)-en-8-ol
(1E,4R,5R,8R)-8-O-[(E)-p-coumaroyl]-4,5-epoxyhumula-1(10)-en-8-ol
(1E,5R,8R)-8-O-[(E)-p-coumaroyl]-5-hydroxyhumula-1(10),4-(15)-dien-8-ol
(Z)-10-demethoxy-12-hydroxygeissovelline
C22H28N2O4 (384.20489680000003)
(6R,11S,13S)-6,11,13-trihydroxy-2,3-seco-14-labden-2,8-olid-3-oic acid|rhizophorin A
Me ester,di-Ac-(7S,8Z)-7,16-Dihydroxy-8-hexadecenoic acid
Resibufogenin
Annotation level-1 Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.
Megestrol acetate
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D019167 - Appetite Stimulants C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D000970 - Antineoplastic Agents
[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate
C24H32O4_2-Propenoic acid, 3-phenyl-, (1R,2R,3S,4R,6E,10S)-2-hydroxy-6,10-dimethyl-3-(1-methylethyl)-11-oxabicyclo[8.1.0]undec-6-en-4-yl ester, (2E)
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate
Zipeprol
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
5-[(Z)-12-(3,5-dihydroxyphenyl)dodec-8-enyl]benzene-1,3-diol_major
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_99.4\\%
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_major
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_84.2\\%
Ala Pro Val Val
C18H32N4O5 (384.23725820000004)
Ala Val Pro Val
C18H32N4O5 (384.23725820000004)
Ala Val Val Pro
C18H32N4O5 (384.23725820000004)
Gly Ile Pro Val
C18H32N4O5 (384.23725820000004)
Gly Ile Val Pro
C18H32N4O5 (384.23725820000004)
Gly Leu Pro Val
C18H32N4O5 (384.23725820000004)
Gly Leu Val Pro
C18H32N4O5 (384.23725820000004)
Gly Pro Ile Val
C18H32N4O5 (384.23725820000004)
Gly Pro Leu Val
C18H32N4O5 (384.23725820000004)
Gly Pro Val Ile
C18H32N4O5 (384.23725820000004)
Gly Pro Val Leu
C18H32N4O5 (384.23725820000004)
Gly Val Ile Pro
C18H32N4O5 (384.23725820000004)
Gly Val Leu Pro
C18H32N4O5 (384.23725820000004)
Gly Val Pro Ile
C18H32N4O5 (384.23725820000004)
Gly Val Pro Leu
C18H32N4O5 (384.23725820000004)
Ile Gly Pro Val
C18H32N4O5 (384.23725820000004)
Ile Gly Val Pro
C18H32N4O5 (384.23725820000004)
Ile Pro Gly Val
C18H32N4O5 (384.23725820000004)
Ile Pro Val Gly
C18H32N4O5 (384.23725820000004)
Ile Val Gly Pro
C18H32N4O5 (384.23725820000004)
Ile Val Pro Gly
C18H32N4O5 (384.23725820000004)
Leu Gly Pro Val
C18H32N4O5 (384.23725820000004)
Leu Gly Val Pro
C18H32N4O5 (384.23725820000004)
Leu Pro Gly Val
C18H32N4O5 (384.23725820000004)
Leu Pro Val Gly
C18H32N4O5 (384.23725820000004)
Leu Val Gly Pro
C18H32N4O5 (384.23725820000004)
Leu Val Pro Gly
C18H32N4O5 (384.23725820000004)
Pro Ala Val Val
C18H32N4O5 (384.23725820000004)
Pro Gly Ile Val
C18H32N4O5 (384.23725820000004)
Pro Gly Leu Val
C18H32N4O5 (384.23725820000004)
Pro Gly Val Ile
C18H32N4O5 (384.23725820000004)
Pro Gly Val Leu
C18H32N4O5 (384.23725820000004)
Pro Ile Gly Val
C18H32N4O5 (384.23725820000004)
Pro Ile Val Gly
C18H32N4O5 (384.23725820000004)
Pro Leu Gly Val
C18H32N4O5 (384.23725820000004)
Pro Leu Val Gly
C18H32N4O5 (384.23725820000004)
Pro Val Ala Val
C18H32N4O5 (384.23725820000004)
Pro Val Gly Ile
C18H32N4O5 (384.23725820000004)
Pro Val Gly Leu
C18H32N4O5 (384.23725820000004)
Pro Val Ile Gly
C18H32N4O5 (384.23725820000004)
Pro Val Leu Gly
C18H32N4O5 (384.23725820000004)
Pro Val Val Ala
C18H32N4O5 (384.23725820000004)
Val Ala Pro Val
C18H32N4O5 (384.23725820000004)
Val Ala Val Pro
C18H32N4O5 (384.23725820000004)
Val Gly Ile Pro
C18H32N4O5 (384.23725820000004)
Val Gly Leu Pro
C18H32N4O5 (384.23725820000004)
Val Gly Pro Ile
C18H32N4O5 (384.23725820000004)
Val Gly Pro Leu
C18H32N4O5 (384.23725820000004)
Val Ile Gly Pro
C18H32N4O5 (384.23725820000004)
Val Ile Pro Gly
C18H32N4O5 (384.23725820000004)
Val Leu Gly Pro
C18H32N4O5 (384.23725820000004)
Val Leu Pro Gly
C18H32N4O5 (384.23725820000004)
Val Pro Ala Val
C18H32N4O5 (384.23725820000004)
Val Pro Gly Ile
C18H32N4O5 (384.23725820000004)
Val Pro Gly Leu
C18H32N4O5 (384.23725820000004)
Val Pro Ile Gly
C18H32N4O5 (384.23725820000004)
Val Pro Leu Gly
C18H32N4O5 (384.23725820000004)
Val Pro Val Ala
C18H32N4O5 (384.23725820000004)
Val Val Ala Pro
C18H32N4O5 (384.23725820000004)
Val Val Pro Ala
C18H32N4O5 (384.23725820000004)
(22E)-12α-Hydroxy-3-oxochola-1,4,22-trien-24-oic Acid
(-)-Pyrifolidine
Cinnzeylanol
4,5-Dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-1,4,4a,5,6,7,8,8a-octahydro-1-naphthalenyl hexanoate
Berkeleylactone E
Berkeleylactone K
Cardiogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides
1-(2,4,6-Trihydroxyphenyl)-6Z,9Z,12Z,15Z-octadecatetraen-1-one
TRIMETHYL CIS,CIS-1,3,5-TRIPROPYL-1,3,5-CYCLOHEXANETRICARBOXYLATE
bis[3-(trimethoxysilyl)propyl]ethylene diamine
C14H36N2O6Si2 (384.21117960000004)
[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic acid 1,1-dimethylethyl ester
tert-butyl 4-(2-oxospiro[cyclohexane-1,3-indole]-1-yl)piperidine-1-carboxylate
butyl prop-2-enoate,6-methylheptyl prop-2-enoate,prop-2-enoic acid
TERT-BUTYL 4-((3-(CYCLOPROPYLAMINO)QUINOXALIN-2-YL)OXY)PIPERIDINE-1-CARBOXYLATE
1-(2,6-Diisopropylphenyl)-3-(2,4,6-trimethylphenyl)-4,5-dihydroimidazolium chloride
C24H33ClN2 (384.23321280000005)
(2E,8R)-8-({3,6-dideoxy-4-O-[(2E)-2-methylbut-2-enoyl]-alpha-L-arabino-hexopyranosyl}oxy)non-2-enoic acid
Desfuranoazadiradione
A limonoid that is azadiradione in which the furanyl group at position 17 is replaced by a hydrogen. It has been isolated from Azadirachta indica.
plakortolide R
An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.
Estra-1,3,5(10)-triene-3,16alpha-diol, dipropionate
1-[4-(Benzyloxy)-3-methoxyphenyl]-5-hydroxydecan-3-one
3-(5-{[4-(Aminomethyl)piperidin-1-Yl]methyl}-1h-Indol-2-Yl)-1h-Indazole-6-Carbonitrile
(S)-N-(4-Carbamimidoylbenzyl)-1-(3-Cyclohexylpropanoyl)pyrrolidine-2-Carboxamide
C22H32N4O2 (384.25251319999995)
Ethynodiol Diacetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Estradiol dipropionate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Butyl [2-cyclohexyl-6-(pyrrolidin-1-yl)-1H-benzimidazol-5-yl]carbamate
C22H32N4O2 (384.25251319999995)
4,4'-Bis(2-hydroxyethylethylamino)-2,2'-dimethylazobenzene
C22H32N4O2 (384.25251319999995)
(E)-7-[3-[(E)-3-hydroxy-4-phenylpent-1-enyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid
[(1R,2R,3S,4R,6E,10S)-2-hydroxy-6,10-dimethyl-3-propan-2-yl-11-oxabicyclo[8.1.0]undec-6-en-4-yl] (E)-3-phenylprop-2-enoate
acetic acid [(17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] ester
(2S)-2-[[(2S)-2-amino-1-oxopropyl]amino]-3-methyl-N-[(2S)-1-(1-naphthalenylamino)-1-oxopropan-2-yl]butanamide
2-[(2-amino-1-oxopropyl)amino]-3-methyl-N-[1-(1-naphthalenylamino)-1-oxopropan-2-yl]butanamide
[(2S,4aS,10aR)-6-acetyloxy-1,1,4a-trimethyl-7-propan-2-yl-2,3,4,10a-tetrahydrophenanthren-2-yl] acetate
rel-(2R,5S,7S,10S)-10-Methyl-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-6-methylenespiro[4.5]decan-7-ol
A natural product found in Carthamus oxyacantha and Carduncellus mareoticus.
N-tert-butyl-2-[2-ethoxy-4-[(2-phenylethylamino)methyl]phenoxy]acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(oxane-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(oxane-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
(1R,5S)-6-[(3-methoxyphenyl)methyl]-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
N-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
(1S,5R)-3-[(3-methoxyphenyl)methyl]-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
2-cyclopropyl-1-[(2R,3S)-2-(hydroxymethyl)-1-(4-oxanylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
13,14-dihydro-15-oxo-20-carboxy-PGF2alpha
A member of the class of prostaglandins Falpha that is 15-oxo-prostaglandin F2alpha in which the methyl group has been oxidised to the corresponding carboxylic acid and in which the double bond at positions 13-14 has been reduced to a single bond.
dihydrostemphyloxin I
An octahydronaphthalene that is stemphyloxin I in which the C=C bond of the enol moiety has been reduced to a C-C bond.
(5S,6Z,8E,10E,12R,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,10,14-tetraenoic acid
[(8S,9R,10S,13R,14R,17S)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
(2Z,10Z,12E,14Z)-16-(3,5-dihydroxyphenyl)-2-ethylidenehexadeca-10,12,14-trienoic acid
O-(2-O-Octanoyl-L-glycero-3-phospho)choline
C16H35NO7P+ (384.21510300000006)
2-[Hydroxy-(2-hydroxy-3-octanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
C16H35NO7P+ (384.21510300000006)
2-[2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethyl]-N,N,1-trimethylquinolin-1-ium-6-amine
(2R)-1-(dimethylamino)-2-[4-[(4-methoxy-3-methylphenyl)methyl]-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]propan-2-ol
[(8R,9R,10R,13S,14S,17S)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
2-[Hydroxy-(2-hydroxy-3-nonoxypropoxy)phosphoryl]oxyethyl-trimethylazanium
C17H39NO6P+ (384.25148640000003)
Ibutilide
C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker
Scillarenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides
mbas#3
A 4-O-[(E)-2-methyl-2-butenoyl]ascaroside derived from (2E,8R)-8-hydroxynon-2-enoic acid. It is a metabolite of the nematode Caenorhabditis elegans.
12alpha-Hydroxy-3-oxochola-1,4,6-trien-24-oic Acid
soppiline C
A member of the class of resorcinols that is 16-(3,5-dihydroxyphenyl)hexadecanoic acid which carries cis double bonds at positions 10 and 14, a trans double bond at position 12, and an ethylidene group at position 2.